University of Bern
Bern, Canton of Bern, 3012, Switzerland
NCT Number: NCT05651737
The ongoing warfare and economic instability in the Middle East and in North Africa causes many people to leave their home countries. Arrived in a host countries, in this example, in Switzerland, they face a lot of structural and psychosocial hurdles. Particularly in the first years, building up a certain quality of life is complicated and challenging. To support this process, the Swiss Red Cross and the University of Bern have developed the Sui app. It contains structural and social information as well as low-intensity psychological tools to provide support to the everyday life of Arabic-speaking people in Switzerland.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bern, Canton of Bern, 3012, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Sui app contains the following chapters:
6 well-being chapters on: stress, sleep, resources throughout the day, chronic pain, emotion regulation, audio exercises 9 Swiss-specific information chapters on: housing, health (two sub-chapters), finances, asylum process, residence status, social integration, occupational integration, family reunification
Time frame: Baseline
Measured by the WHO Quality of Life Short Version (WHOQOL-BREF, 4 domain scores, mean score multiplied by 4, 0 (low) to 100 (high) range)
Time frame: Post (after 8 weeks)
Measured by the WHO Quality of Life Short Version (WHOQOL-BREF, 4 domain scores, mean score multiplied by 4, 0 (low) to 100 (high) range)
Time frame: Follow-Up (after 16 weeks)
Measured by the WHO Quality of Life Short Version (WHOQOL-BREF, 4 domain scores, mean score multiplied by 4, 0 (low) to100 (high) range)
Time frame: Post (after 8 weeks), Follow-Up (after 16 weeks)
Measured by the Questionnaire on satisfaction with the treatment (ZUF-8, 1(low) to 4 (high) scores) adapted for "app" as intervention
Time frame: Baseline, Post (after 8 weeks), Follow-Up (after 16 weeks)
Measured by the Self-stigma of mental illness scale short form (SSMIS-SF, 1(strongly disagree) to 9 (strongly agree) scores)
Time frame: Baseline, Post (after 8 weeks), Follow-Up (after 16 weeks)
Measured by the Post traumatic stress disorder checklist scale according to DSM-5 (PCL-5, 0 (not at all) to 80 (extremely) range)
Time frame: Baseline, Post (after 8 weeks), Follow-Up (after 16 weeks)
Measured by the Patient Health Questionnaire 15 (PHQ-15, 0 (normal) to 30 (severe) symptom range )
Time frame: Baseline, Post (after 8 weeks), Follow-Up (after 16 weeks)
Measured by the Generalised Anxiety Disorder 7 (GAD-7, 0 (minimal) to 21 (severe) symptom range)
Time frame: Baseline, Post (after 8 weeks), Follow-Up (after 16 weeks)
Measured by the Patient Health Questionnaire 9 (PHQ-9, 0 (no suspicion of) to 27 (suspicion of severe) depression range)
Time frame: Baseline, Post (after 8 weeks), Follow-Up (after 16 weeks)
Measured by the Post-migratory life difficulties Checklist (PMLD-CL, 0 (no) to 4 (very serious) post migration problem scores)
University of Bern
Other
Efficacy of an Unguided or Peer-guided App-based Psychosocial Intervention to Enhance Quality of Life in Arabic-speaking Refugees Residing in Switzerland: A Randomized Controlled Trial
Acronym: Sui
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04041401
Anxiety, Anxiety Disorders
Tooting, United Kingdom
View Trial DetailsNCT04961697
Anxiety, Anxiety Disorders
Rio de Janeiro, Brazil
View Trial DetailsNCT04460976
Acceptance of Diagnosis, Anxiety
Stockholm, Sweden
View Trial DetailsNCT02067559
Anxiety, Anxiety Disorders
Winnipeg, Manitoba, Canada
View Trial Details